Benzinga · Jul 24, 2026
New AI ETF Bets on Healthcare's $9 Trillion Opportunity
Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics and patient care.
NASDAQ · HLTH
Healthcare · Medical - Healthcare Information Services
$27.55
Up+$0.03 (+0.11%)
Updated Aug 16, 2026, 6:52 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
HLTH closed at $27.55 after 19 trading sessions, up 8.86% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $27.3248 | $27.5552 | $27.3248 | $27.5548 | 5.13K |
| Aug 13, 2026 | $27.90 | $28.02 | $27.525 | $27.5313 | 43.23K |
| Aug 12, 2026 | $27.75 | $27.8338 | $27.6901 | $27.8338 | 2.25K |
| Aug 11, 2026 | $27.80 | $27.97 | $27.64 | $27.8482 | 11.22K |
| Aug 10, 2026 | $28.00 | $28.00 | $27.28 | $27.7503 | 26.19K |
| Aug 7, 2026 | $26.68 | $27.1475 | $26.64 | $27.1475 | 5.23K |
| Aug 6, 2026 | $26.44 | $26.44 | $26.10 | $26.2282 | 6.06K |
| Aug 5, 2026 | $26.60 | $26.755 | $26.60 | $26.6957 | 5.66K |
| Aug 4, 2026 | $26.09 | $26.51 | $26.09 | $26.4994 | 5.99K |
| Aug 3, 2026 | $25.66 | $25.8722 | $25.66 | $25.8722 | 2.3K |
| Jul 31, 2026 | $25.5099 | $25.6599 | $25.5099 | $25.655 | 1.05K |
| Jul 30, 2026 | $25.50 | $25.8095 | $25.50 | $25.8095 | 1.84K |
| Jul 29, 2026 | $25.106 | $25.415 | $25.106 | $25.415 | 597 |
| Jul 28, 2026 | $25.00 | $25.256 | $25.00 | $25.256 | 1.86K |
| Jul 27, 2026 | $25.15 | $25.36 | $25.11 | $25.1782 | 3.26K |
| Jul 24, 2026 | $25.31 | $25.31 | $25.205 | $25.205 | 3.75K |
| Jul 23, 2026 | $25.47 | $25.4739 | $25.33 | $25.4739 | 27.68K |
| Jul 22, 2026 | $25.19 | $25.26 | $25.17 | $25.1865 | 796.45 |
| Jul 21, 2026 | $24.88 | $25.3116 | $24.88 | $25.3116 | 11.09K |
The latest Smart Investors Daily articles mentioning HLTH.
HLTH research
Company profile and research snapshot.
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 14, 2024 | BTIG | Neutral | — |
| Nov 10, 2023 | Goldman Sachs | Neutral | — |
| Jun 5, 2023 | Goldman Sachs | Neutral | — |
| Jun 2, 2023 | Goldman Sachs | Neutral | — |
| May 15, 2023 | BTIG | Buy | — |
No generated briefing is available yet.
Benzinga · Jul 24, 2026
Tema's new Healthcare AI ETF (HLTH), targets AI-powered drug discovery, diagnostics, robotics and patient care.
Zacks Investment Research · May 9, 2024
AMN Healthcare (AMN) delivered earnings and revenue surprises of 4.30% and 0.73%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research · Oct 12, 2023
Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks Investment Research · Aug 9, 2023
Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 3.77% and 10.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HLTH.
No results
No recent SID articles mention HLTH.